Valiant Organics Limited has informed the Exchange about Investor Presentation

Valiant Organics Limited has filed its Q1 FY2025-26 investor presentation with the exchanges. Operational revenue stood at INR 2,044 million, up 21.7% year-on-year but flat sequentially (up 0.3% QoQ). Operating EBITDA came in at INR 248 million with a margin of 12.13%, expanding 278 basis points YoY and 217 bps QoQ, driven by higher gross profit (up 20% YoY, 11% QoQ) and better cost efficiency. Profit after tax was INR 82 million versus a small loss in Q1 FY25, with EPS at INR 2.93. Hydrogenation remains the largest revenue contributor at 53% of Q1 FY26 sales, followed by Ammonolysis at 23% and Chlorination at 19%. The company operates 6 manufacturing units with a combined capacity of 70,000 TPA and a market cap of approximately INR 11,612 million as of June 30, 2025.